CRYSTAL BAUMANN: Open Payments
NPI 1982126306 · ALACHUA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,018 in 54 payments from 13 companies in 2025. Trend: 2023 $1,377 · 2024 $1,352 · 2025 $1,018
Food & beverage: $819Long term medical supply or device loan: $199
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $283 |
| Novartis Pharmaceuticals Corporation | 2 | $199 |
| Lilly USA, LLC | 10 | $176 |
| PFIZER INC. | 3 | $53 |
| Medtronic, Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Abbott Laboratories | 2 | $37 |
| Amgen Inc. | 2 | $36 |
| Exact Sciences Corporation | 2 | $32 |
Products named: KISQALI, MOUNJARO, Rybelsus, Ozempic, INTERSTIM, JARDIANCE, FREESTYLE LIBRE 3, FARXIGA.
Industry payments across FL — which companies pay providers there.
